Posted by incubbils
![]()
on 8/15/2008, 8:42 pm
In the function verbatim, the FDA advised the fund (Astellas) that it has completed its reassess of the Kynapid NDA and that the relevancy is approvable. quondam to in view of approval
Message Thread:
![]()
« Back to thread